Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 68 articles: HTML format

Single Articles

September 2025
1. FIELD TS
   In AIS due to LVO presenting within 4.5 h of onset, adding tenecteplase to EVT increased functional independence at 90 d.
   Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03337.
   PubMed     Abstract available
   
   
   August 2025
2. PAGANO MB, Stanworth SJ, Dennis J, Bakhtary S, et al
   Red Cell Transfusion in Acute Myocardial Infarction: AABB International Clinical Practice Guidelines.
   Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-00706.
   PubMed     Abstract available
   
   
   
3. OGUNTALA JO, Yan AT
   Toward Evidence-Based Transfusion for Anemia in Acute Myocardial Infarction: Still an Unfinished Story.
   Ann Intern Med. 2025 Aug 19. doi: 10.7326/ANNALS-25-02486.
   PubMed    
   
   
   
4. CENTOR RM, Kip K, Saeed A
   Web Exclusive. Annals On Call - Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes.
   Ann Intern Med. 2025;178:e2503594OC.
   PubMed    
   
   
   July 2025
5. AGGARWAL R, Wadhera RK, Chiu N, Szarek M, et al
   Cardiovascular Risk Factor and Disease Mortality Among Asian Indian, Chinese, and Filipino Adults in the United States, 2018 to 2023.
   Ann Intern Med. 2025 Jul 29. doi: 10.7326/ANNALS-25-00108.
   PubMed    
   
   
   
6. SHAHID M, Gandhi GY
   In patients with diabetes and previous MI, high-dose multivitamins and minerals did not reduce CV events.
   Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-02174.
   PubMed     Abstract available
   
   
   June 2025
7. SAEED A, Mulukutla SR, Thoma F, Lemon L, et al
   Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.
   Ann Intern Med. 2025 Jun 17. doi: 10.7326/ANNALS-24-00775.
   PubMed     Abstract available
   
   
   
8. 
   Summary for Patients: Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes.
   Ann Intern Med. 2025 Jun 17. doi: 10.7326/ANNALS-24-00775.
   PubMed    
   
   
   
9. BATUR P
   Some combined and progestin-only contraceptives were linked to increased risk for ischemic stroke and myocardial infarction.
   Ann Intern Med. 2025 Jun 3. doi: 10.7326/ANNALS-25-01774.
   PubMed     Abstract available
   
   
   
10. OGUNTALA JO, Yan AT
    In AF with stable CAD, an OAC alone does not increase ischemic events and reduces major bleeding vs. OAC + SAPT at a mean 22 mo.
    Ann Intern Med. 2025;178:JC65.
    PubMed     Abstract available
    
    
    
11. DUNN AS
    In ACS with DES, de-escalating DAPT to ticagrelor alone vs. standard DAPT reduces major bleeding without increasing ischemic events.
    Ann Intern Med. 2025;178:JC66.
    PubMed     Abstract available
    
    
    
12. AU YEUNG SL, Luo S, Schooling CM
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2025;178:905.
    PubMed    
    
    
    
13. SELINGER S
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2025;178:904-905.
    PubMed    
    
    
    
14. LIN YH, Lin KJ, Chen JY, Juang HH, et al
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2025;178:905-906.
    PubMed    
    
    
    
15. YEAP BB, Wittert GA, Wu FCW, Vanderschueren D, et al
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2025;178:906-907.
    PubMed    
    
    
    May 2025
16. MANSOOR H, Elgendy IY
    In AF with recent ACS or PCI, apixaban reduced total bleeding vs. VKA; aspirin increased total bleeding vs. placebo at 6 mo.
    Ann Intern Med. 2025;178:JC57.
    PubMed     Abstract available
    
    
    
17. KHATTAK S, Al-Ansari A, Alfaraidhy M, Rajah F, et al
    Cardiology: What You May Have Missed in 2024.
    Ann Intern Med. 2025;178.
    PubMed     Abstract available
    
    
    April 2025
18. CIACCI P, Romiti GF, Corica B
    In older adults with severe AS and complex CAD, PCI + TAVI vs. SAVR + CABG reduced patient-oriented outcomes at 1 y.
    Ann Intern Med. 2025;178:JC45.
    PubMed     Abstract available
    
    
    March 2025
19. NTSEKHE M
    Low Prevalence of Coronary Artery Disease Among Ugandans With and Without HIV: Local Anomaly or Regional Reality?
    Ann Intern Med. 2025 Mar 12. doi: 10.7326/ANNALS-24-03940.
    PubMed    
    
    
    
20. SIEDNER MJ, Ghoshhajra B, Erem G, Nassanga R, et al
    Epidemiology of Coronary Atherosclerosis Among People Living With HIV in Uganda : A Cross-Sectional Study.
    Ann Intern Med. 2025 Mar 12. doi: 10.7326/ANNALS-24-02233.
    PubMed     Abstract available
    
    
    
21. LADER EW
    In previous MI with ventricular tachycardia (VT), catheter ablation reduced mortality or VT events more than antiarrhythmic drug therapy at 4 y.
    Ann Intern Med. 2025 Mar 4. doi: 10.7326/ANNALS-25-00336.
    PubMed     Abstract available
    
    
    
22. OGUNTALA JO, Yan AT
    In acute MI and acute or chronic anemia, liberal vs. restrictive transfusion did not affect recurrent MI or death.
    Ann Intern Med. 2025 Mar 4. doi: 10.7326/ANNALS-25-00161.
    PubMed     Abstract available
    
    
    
23. KELSEY MD, Newby LK
    In patients with acute MI, spironolactone did not reduce cardiac events at 3 y.
    Ann Intern Med. 2025;178:JC33.
    PubMed     Abstract available
    
    
    
24. KELSEY MD, Newby LK
    In patients with acute MI, colchicine did not reduce cardiac events at 3 y.
    Ann Intern Med. 2025;178:JC32.
    PubMed     Abstract available
    
    
    February 2025
25. LEE YJ, Gao X, Lee SH, Kan J, et al
    De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome : A Systemic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials.
    Ann Intern Med. 2025 Feb 18. doi: 10.7326/ANNALS-24-03102.
    PubMed     Abstract available
    
    
    
26. 
    Annals Video Summary - De-escalating Dual Antiplatelet Therapy to Ticagrelor Monotherapy in Acute Coronary Syndrome.
    Ann Intern Med. 2025 Feb 18:e2500013VS. doi: 10.7326/ANNALS-25-00013.
    PubMed    
    
    
    
27. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Care of Patients With Low Cardiac Risk but Incidental Coronary Artery Calcification.
    Ann Intern Med. 2025;178:e2500667CG.
    PubMed    
    
    
    January 2025
28. MASUDA S, Fukasawa T, Matsuda S, Kawakami K, et al
    Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis : A Target Trial Emulation.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03237.
    PubMed     Abstract available
    
    
    
29. MORENO R
    In asymptomatic severe AS, early surgery vs. conservative therapy reduced a composite of death, MI, stroke, or HF hospitalization at 63 mo.
    Ann Intern Med. 2025 Jan 7. doi: 10.7326/ANNALS-24-03367.
    PubMed     Abstract available
    
    
    
30. RICH MW
    In adults aged >/=75 y with NSTEMI, an invasive vs. conservative strategy did not improve a composite outcome at a median 4.1 y.
    Ann Intern Med. 2025;178:JC5.
    PubMed     Abstract available
    
    
    December 2024
31. 
    Correction: Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs.
    Ann Intern Med. 2024 Dec 17. doi: 10.7326/ANNALS-24-03386.
    PubMed    
    
    
    
32. NADERIAN M, Norland K, Schaid DJ, Kullo IJ, et al
    Development and Evaluation of a Comprehensive Prediction Model for Incident Coronary Heart Disease Using Genetic, Social, and Lifestyle-Psychological Factors: A Prospective Analysis of the UK Biobank.
    Ann Intern Med. 2024 Dec 10. doi: 10.7326/ANNALS-24-00716.
    PubMed     Abstract available
    
    
    
33. CENTOR RM, Carson JL, Brooks MM
    Web Exclusive. Annals On Call - Transfusion Thresholds in Myocardial Infarction.
    Ann Intern Med. 2024;177:e2403587OC.
    PubMed    
    
    
    
34. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Cholesterol Management in Older Patients After Myocardial Infarction.
    Ann Intern Med. 2024;177:e2403798CG.
    PubMed    
    
    
    
35. LADER E
    In stable CAD and aortic stenosis, adding routine PCI to TAVI reduced MACE but increased bleeding at 2 y.
    Ann Intern Med. 2024;177:JC139.
    PubMed     Abstract available
    
    
    
36. KESARWANI M
    After PCI for ACS or stable CAD, DAPT for 1 mo vs. >1 mo reduces major bleeding without increasing stent thrombosis.
    Ann Intern Med. 2024;177:JC138.
    PubMed     Abstract available
    
    
    November 2024
37. GIBSON LE, Wiener-Kronish JP, Fleisher LA
    From Risk to Recovery: Looking Ahead to the Next 50 Years of Preoperative Cardiovascular Assessment.
    Ann Intern Med. 2024 Nov 12. doi: 10.7326/ANNALS-24-02405.
    PubMed    
    
    
    October 2024
38. WOODRUFF RC, Kaholokula JK, Riley L, Tong X, et al
    Cardiovascular Disease Mortality Among Native Hawaiian and Pacific Islander Adults Aged 35 Years or Older, 2018 to 2022.
    Ann Intern Med. 2024 Oct 15. doi: 10.7326/M24-0801.
    PubMed     Abstract available
    
    
    
39. FITCH KV, Zanni MV, Manne-Goehler J, Diggs MR, et al
    Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized Trial.
    Ann Intern Med. 2024 Oct 8. doi: 10.7326/ANNALS-24-00944.
    PubMed     Abstract available
    
    
    
40. PORTELA GT, Carson JL, Swanson SA, Alexander JH, et al
    Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/M24-0571.
    PubMed     Abstract available
    
    
    
41. BLOCH EM, Tobian AAR
    Relaxing Transfusion Thresholds for Patients With Myocardial Infarction: Findings From the MINT Trial.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/M24-0895.
    PubMed    
    
    
    
42. SHARMA M, Srivastva A
    In ischemic stroke treated within 4.5 h, reteplase vs. alteplase increased excellent functional outcome at 90 d.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/ANNALS-24-02228.
    PubMed     Abstract available
    
    
    September 2024
43. SEE C, Mooghali M, Dhruva SS, Ross JS, et al
    Class I Recalls of Cardiovascular Devices Between 2013 and 2022 : A Cross-Sectional Analysis.
    Ann Intern Med. 2024 Sep 17. doi: 10.7326/ANNALS-24-00724.
    PubMed     Abstract available
    
    
    
44. MINHAS AMK, Virani SS, Michos ED, Nambi V, et al
    Comparing Cardiovascular Risk Classification of U.S. Adults According to Pooled Cohort Equations and PREVENT Equations: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey.
    Ann Intern Med. 2024 Sep 3. doi: 10.7326/ANNALS-24-00074.
    PubMed    
    
    
    
45. FATH AR, Elgendy IY
    After ACS, telemedicine-based care with remote patient monitoring vs. usual care reduced hospital readmissions at 6 mo.
    Ann Intern Med. 2024;177:JC105.
    PubMed     Abstract available
    
    
    
46. MUKHERJEE D
    In patients with NSTE-ACS and previous CABG, routine invasive vs. conservative management does not improve outcomes.
    Ann Intern Med. 2024;177:JC104.
    PubMed     Abstract available
    
    
    August 2024
47. CHAITOFF A, Bendicksen L, Feldman WB, Zheutlin AR, et al
    Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention.
    Ann Intern Med. 2024 Aug 27. doi: 10.7326/ANNALS-24-00308.
    PubMed    
    
    
    
48. ANDERSON TS, Yeh RW, Herzig SJ, Marcantonio ER, et al
    Trends and Disparities in Ambulatory Follow-Up After Cardiovascular Hospitalizations : A Retrospective Cohort Study.
    Ann Intern Med. 2024 Aug 6. doi: 10.7326/M23-3475.
    PubMed     Abstract available
    
    
    
49. CLIFFORD C, Yan AT
    After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE.
    Ann Intern Med. 2024;177:JC86.
    PubMed     Abstract available
    
    
    
50. SULEIMAN B, Granger CB
    In MI with preserved LVEF, long-term beta-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y.
    Ann Intern Med. 2024;177:JC88.
    PubMed     Abstract available
    
    
    July 2024
51. KEPPEL S, Borzak S
    In adults with AMI who are at risk for HF, empagliflozin did not reduce a composite of first HF hospitalization or all-cause death at 18 mo.
    Ann Intern Med. 2024;177:JC74.
    PubMed     Abstract available
    
    
    June 2024
52. GUPTA M, Gulati S, Nasir K, Sarraju A, et al
    Aspirin Use Prevalence for Cardiovascular Disease Prevention Among U.S. Adults From 2012 to 2021.
    Ann Intern Med. 2024 Jun 25. doi: 10.7326/M24-0427.
    PubMed    
    
    
    
53. GUALLAR E, Bravo PE, Ferrari VA
    Feeling the Heat: Cardiovascular Consequences of Heat Exposure Under Controlled Experimental Conditions.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M24-0882.
    PubMed    
    
    
    
54. BARRY H, Iglesies-Grau J, Chaseling GK, Paul J, et al
    The Effect of Heat Exposure on Myocardial Blood Flow and Cardiovascular Function.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M24-3504.
    PubMed     Abstract available
    
    
    
55. 
    Correction: Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2024 Jun 4. doi: 10.7326/ANNALS-24-00550.
    PubMed    
    
    
    
56. CHIA JE, Mukherjee D
    After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit.
    Ann Intern Med. 2024;177:JC64.
    PubMed     Abstract available
    
    
    May 2024
57. 
    Annals Video Summary - Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2024 May 14:eM240479. doi: 10.7326/M24-0479.
    PubMed    
    
    
    
58. YEAP BB, Marriott RJ, Dwivedi G, Adams RJ, et al
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men : Individual Participant Data Meta-analyses.
    Ann Intern Med. 2024 May 14. doi: 10.7326/M23-2781.
    PubMed     Abstract available
    
    
    
59. BATES ER
    In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0026.
    PubMed     Abstract available
    
    
    
60. WEITZ HH, Merli GJ, Carson JL
    Web Exclusive. Annals Consult Guys - Acute Coronary Syndrome and Anemia: When to Transfuse?
    Ann Intern Med. 2024;177:eW240002.
    PubMed    
    
    
    April 2024
61. YEN FS, Hwu CM, Liu JS, Wu YL, et al
    Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.
    Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-1874.
    PubMed     Abstract available
    
    
    
62. GREENWOOD H, Barnes K, Clark J, Ball L, et al
    Long-Term Effect of Salt Substitution for Cardiovascular Outcomes : A Systematic Review and Meta-Analysis.
    Ann Intern Med. 2024 Apr 9. doi: 10.7326/M23-2626.
    PubMed     Abstract available
    
    
    
63. 
    Annals Video Summary - Long-Term Effect of Salt Substitution for Cardiovascular Outcomes: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2024 Apr 9:eM240208. doi: 10.7326/M24-0208.
    PubMed    
    
    
    
64. KIRSCHNER J, Hunter B
    In suspected ACS, hs-cTnI- vs. c-cTnI-guided care was associated with improved outcomes at 5 y in certain subgroups.
    Ann Intern Med. 2024;177:JC41.
    PubMed     Abstract available
    
    
    March 2024
65. WEISS J, Raghu VK, Paruchuri K, Zinzuwadia A, et al
    Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-1898.
    PubMed     Abstract available
    
    
    
66. MUKHERJEE D
    In acute MI and anemia, restrictive vs. liberal transfusion did not differ for a composite of recurrent MI or death at 30 d.
    Ann Intern Med. 2024 Mar 5. doi: 10.7326/J24-0010.
    PubMed     Abstract available
    
    
    
67. BAVISHI C
    In adults with stable angina, PCI vs. a placebo procedure reduced angina symptoms at 12 wk.
    Ann Intern Med. 2024;177:JC28.
    PubMed     Abstract available
    
    
    
68. YONIS H, Granger CB
    In adults aged >/=80 y with NSTE-ACS, an invasive vs. conservative strategy improved outcomes at a median 5.3 y.
    Ann Intern Med. 2024;177:JC27.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.